Background Current evidence suggests an important role of the interleukin‐6 (IL‐6) pathway
in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐related cytokine …

Background Cardiovascular events have been reported in the setting of coronavirus disease‐19
(COVID‐19). It has been hypothesized that systemic inflammation may aggravate …

Background No data are available on sex disparities in prevalence and survival for primary
malignant cardiac tumors ( PMCT ). This study aimed to compare male and female PMCT …

BACKGROUND Immune checkpoint inhibitors (ICIs) are novel therapeutic agents used for
various types of cancer. ICIs have revolutionized cancer treatment and improved clinical …

Background: Depression and anxiety occur more frequently in women and are associated
with an increased risk of cardiovascular disease. Objectives: Data on the association between …

BACKGROUND Timely and accurate identification of subgroup at risk for major adverse
cardiovascular events among patients presenting with acute chest pain remains a challenge. …

Background The development of highly active anti-retroviral therapy (HAART) has markedly
prolonged the life expectancy of individuals with human immunodeficiency virus (HIV). The …

Background: In patients with end-stage heart failure, durable Left Ventricular Assist Devices
(LVADs) can be used as a bridge to transplant or destination therapy. LVADs have been …

Background Atrial fibrillation (AF) is one of the most common arrhythmias encountered in
patients with SARS-CoV-2 infection. There are racial disparities in the incidence of AF and …

Background On March 11, 2020, the World Health Organization declared coronavirus
disease-19 (COVID-19) a pandemic. Nearly five million individuals have since been diagnosed …